May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Heavy Silicone Oil (HSO) as endotamponade in Complicated Retinal Detachment (RD)
Author Affiliations & Notes
  • F. Genovesi–Ebert
    Ophthalmology, Ophthalmic Surgery Division, Pisa, Italy
  • C. Belting
    Ophthalmology, Ophthalmic Surgery Division, Pisa, Italy
  • A. Vento
    Ophthalmology, Ophthalmic Surgery Division, Pisa, Italy
  • E. Di Bartolo
    Ophthalmology, Ophthalmic Surgery Division, Pisa, Italy
  • M. Palla
    Ophthalmology, Ophthalmic Surgery Division, Pisa, Italy
  • S. Rizzo
    Ophthalmology, Ophthalmic Surgery Division, Pisa, Italy
  • Footnotes
    Commercial Relationships  F. Genovesi–Ebert, None; C. Belting, None; A. Vento, None; E. Di Bartolo, None; M. Palla, None; S. Rizzo, None.
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 2017. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      F. Genovesi–Ebert, C. Belting, A. Vento, E. Di Bartolo, M. Palla, S. Rizzo; Heavy Silicone Oil (HSO) as endotamponade in Complicated Retinal Detachment (RD) . Invest. Ophthalmol. Vis. Sci. 2004;45(13):2017.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: to evaluate the efficacy and safety of HSO as heavier than water retinal endotamponade in the treatment of complicated retinal detachment. Methods: New HSOs were used after pars plana vitrectomy to treat complicated RD. 29 eyes of 29 patients affected by recurrent RD for inferior tears and PVR (24), were semi–randomly injected with Oxane: Silicone Oil 5.700 csks–RMN3 mixture (viscosity 3.300 mPas, density 1,02 gr/cm3: 14eyes ) and Densiron 68 Silicone Oil 5000 csk–F6H8 (viscosity 1.400 mPas, density 1.06 gr/cm3: 15eyes). HSOs were injected as endotamponade at the end of the surgery. 12 o’clock iridectomy was performed in the aphakic patients (6 eyes). The mean duration of the endotamponade was 72 days (range 40–118). The HSOs were replaced with BSS, air, mixture air–gas or PDMS depending on retinal conditions. Main outcome measures were anatomic success and complications due to HSO. Follow–up ranged from 2 to 6 months. Results:After HSO removal HSO was exchanged with air (10 eyes), gas (15) or PDMS (4). 3 patients presented recurrent RD after the absorption of the gas. Retinal reattachment was achieved in 22 eyes at the end of the follow–up. HSOs were easily handled during the surgery. No intraoperative complications were observed. Postoperative complications were: HSO in the anterior chamber and pharmacologically controlled hypertonus in 1 eye, and epiretinal membranes in the upper sector causing DR recurrence in 4 cases. Densiron and Oxane apparently showed the same anatomic success and complications rate. Conclusions:These preliminary results show that HSOs can be used as an effective and safe endotamponade in the treatment of complicated RD. Complications are few and similar to those observed with conventional Silicone Oil, even if PVR occurred in the superior sector. In this study the behavior of the two HSOs used appeared comparable.

Keywords: retina • retinal detachment • vitreous substitutes 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×